Metagenomi Therapeutics (MGX) Q4 2025 Earnings

Nov 11Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.75
-0.62
-0.5
-0.37

Details

Expected EPS
-0.58448
Actual EPS
-0.55
Surprise EPS
0.03
Surprise Percent
+5.9%

Description

⁨Metagenomi Therapeutics⁩ (⁦MGX⁩) has reported earnings of ⁦-0.55⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts